Protara Therapeutics Valuation
| TARA Stock | USD 7.08 0.08 1.14% |
At this time, the company appears to be overvalued. Protara Therapeutics holds a recent Real Value of $5.46 per share. The prevailing price of the company is $7.08. Our model determines the value of Protara Therapeutics from analyzing the company fundamentals such as Shares Outstanding of 53.59 M, return on equity of -0.49, and Shares Owned By Institutions of 53.87 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Protara Therapeutics' price fluctuation is unstable at this time. Calculation of the real value of Protara Therapeutics is based on 3 months time horizon. Increasing Protara Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Protara Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Protara Stock. However, Protara Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.08 | Real 5.46 | Hype 7.08 | Naive 7.4 |
The real value of Protara Stock, also known as its intrinsic value, is the underlying worth of Protara Therapeutics Company, which is reflected in its stock price. It is based on Protara Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Protara Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Protara Therapeutics helps investors to forecast how Protara stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Protara Therapeutics more accurately as focusing exclusively on Protara Therapeutics' fundamentals will not take into account other important factors: About Protara Therapeutics Valuation
The stock valuation mechanism determines Protara Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Protara Therapeutics. We calculate exposure to Protara Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Protara Therapeutics's related companies.Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. Protara Therapeutics, Inc. is headquartered in New York, New York. Artara Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 31 people.
Complementary Tools for Protara Stock analysis
When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |